加拿大卫生部警告加拿大人不要在网上或商店销售不安全、未经授权的GLP-1毒品。 Health Canada warns Canadians against unsafe, unauthorized GLP-1 drugs sold online or in stores.

加拿大卫生部警告加拿大人不要购买未经授权或伪造的GLP-1类药物,如Ozempic、Wegovy、Mounjaro和Zepbound,它们可能含有有害成分、不正确的剂量或污染物。 Health Canada warns Canadians against purchasing unauthorized or counterfeit GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound, which may contain harmful ingredients, incorrect dosages, or contaminants. 这些未经批准的产品在网上或商店销售,对健康构成严重风险,包括感染、过敏反应和不当储存。 These unapproved products, sold online or in stores, pose serious health risks including infections, allergic reactions, and improper storage. 只有持有执照的药店才能合法销售处方药;消费者应通过加拿大卫生部的官方数据库,使用八位数的药物识别号码(DIN)核实产品。 Only licensed pharmacies can legally sell prescription drugs; consumers should verify products using an eight-digit Drug Identification Number (DIN) via Health Canada’s official database. 该机构正在监测市场,查封非法货运,并敦促公众避开带有假标识、无处方要求或价格异常低的网站。 The agency is monitoring the market, seizing illegal shipments, and urging the public to avoid websites with fake logos, no prescription requirements, or unusually low prices. 向加拿大卫生部报告涉嫌制造假冒或副作用。 Report suspected counterfeits or side effects to Health Canada.